We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Fifteen additional synthetic opioids are now under the strictest controls to prevent drug related deaths and ensure anyone caught supplying them faces tough penalties.
First published during the 2022 to 2024 Sunak Conservative government
The Advisory Council's report states that Ketamine should be controlled under the Misuse of Drugs Act 1971.
Ketamine should be upgraded to a Class B drug following increased evidence of bladder damage from frequent misuse, experts have recommended.
The home of Advisory Council on the Misuse of Drugs on GOV.UK. The Advisory Council on the Misuse of Drugs makes recommendations to government on the control of dangerous or otherwise harmful drugs, including classification …
Details of the council's committees and latest meeting minutes.
A review of the evidence on the use and harms of 2-benzyl benzimidazole (nitazene) and piperidine benzimidazolone (brorphine-like) opioids.
The Advisory Council on the Misuse of Drugs has recommended the control of three prescription medicines
A lethal psychedelic drug should be controlled as a Class A substance, according to the Advisory Council on the Misuse of Drugs (ACMD).
In October 2001 the Home Secretary asked the Advisory Council on the Misuse of Drugs to review the classification of cannabis preparations in…
A review of MDMA (‘ecstasy’), its harms and classification under the Misuse of Drugs Act 1971 (2009). The Advisory Council on the Misuse of…
Safe housing key to tackling homeless drug misuse, says ACMD.
The ACMD has recommended that cannabis-derived medicinal products should be placed in Schedule 2 of the Misuse of Drugs Regulations 2001.
The Novel Psychoactive Substances Committee (NPSC) is seeking evidence for its review of the evidence of the misuse and harms of synthetic cathinones in the UK.
In July 2009 the Advisory Council on the Misuse of Drugs (ACMD) provided advice on harmful synthetic compounds.
'Ketamine: a review of use and harm' provides advice from the Advisory Council on the Misuse of Drugs to the Home Secretary.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
This report provides an updated harms assessment of gamma-hydroxybutyric acid (GHB) and related substances.
The Home Secretary has accepted the ACMD’s recommendation to reclassify methylamphetamine to a Class A Drug. Methylamphetamine (commonly referred…
A review of the evidence on the use, harms and prevalence of recently encountered uncontrolled novel benzodiazepines and related compounds (2024 update).
Report of the findings of the ACMD's inquiry on children of problem drug users in the UK.
Letter to the Home Office setting out the ACMD’s review of alkyl nitrites (poppers).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).